Sign up to receive the latest updates

Contact Information

Tel: +44 1789 867523
Fax: +44 1789 450682
Email: info@heartrhythmcongress.org.uk

Heart Rhythm Congress
PO Box 3697
Stratford Upon Avon
Warwickshire
CV37 8YL
UK

Heart Rhythm Congress Facebook
Heart Rhythm Congress LinkedIn
Heart Rhythm Congress Twitter

Monday 10 October

To include

CASES & TRACES (1)
GUCH HEART RHYTHM MANAGEMENT 1
GUCH HEART RHYTHM MANAGEMENT 2
IMPROVING AF OUTCOMES IN THE LAB
IMPROVING ARRHYTHMIA MANAGEMENT (1)
MASTER CLASS DEVICES, PART 1 - PRACTICAL MANAGEMENT ISSUES
MASTER CLASS DEVICES, PART 2 
MASTER CLASS DEVICES, PART 3 - GETTING THE MOST OUT OF CRT
MASTER CLASS EP, PART 1
MODERATED POSTERS (1)
NURSES
OPTIMAL MANAGEMENT OF AF AND VT USING THE LATEST TOOLS AND TECHNIQUES
ORAL ABSTRACTS 1
PAEDIATRIC
PHARMACY WORKSHOP
PHYSIOLOGICAL RATE ADAPTION
RESEARCH SESSION
YOUNG INVESTIGATORS COMPETITION


08:30-12:15 Oral Abstracts 1 - Hall 7

Chair: L Broadhurst & M Squirell
  Rotherham UK; London UK
  Allied Professionals    
08:30 CRYOABLATION FOR PAROXYSMAL ATRIAL FIBRILLATION - IS AN EP LAB REQUIRED? F Champney
Brighton UK
08:45 A PATHWAY TO SAFETY -  ANTICOAGULATION COMPLIANCE IN CIED PATIENTS WITH AF L Maddock
London UK
09:00 UNDERSTANDING THE WAYS IN WHICH OCCUPATION IS AFFECTED BY POSTURAL TACHYCARDIA SYNDROME: A UK OCCUPATIONAL THERAPY PERSPECTIVE J Welford
Middlesbrough UK
09:15 DEVELOPMENT OF AN INTERGRATED SUPPORT PATHWAY FOR PATIENTS FULFILLING NICE CRITERIA FOR AN INTERNAL CARDIOVASCULAR DEBRIBRILLATOR (ICD) IN A DISTRICT GENERAL HOSPITAL J Kemp
Taunton UK
09:30 ARE CARDIOVASCULAR RISK FACTORS ALSO ASSOCIATED WITH THE INCIDENCE OF ATRIAL FIBRILLATION? A SYSTEMATIC REVIEW AND FIELD SYNOPSIS OF 23 FACTORS IN 32 INITIALLY HEALTHY COHORTS OF 20 MILLION PARTICIPANTS V Allan
London UK
09:45 BRAIN MRI FINDINGS IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING CARDIOVERSION Y Persidskikh Minsk BY
10:00 Break    
Chair: M Finlay & M O'Neill
  London UK; London UK
  Basic Science / Sudden Cardiac Death    
10:45  PRELIMINARY ASSESSMENT OF THE "RE-ENTRY VULNERABILITY INDEX" AS A MARKER OF CARDIAC INSTABILITY IN THE HUMAN HEART USING WHOLE-HEART CONTACT EPICARDIAL MAPPING M Orini
London UK
11:00 OPTOGENETIC STIMULATION OF BRAINSTEM'S VAGAL PREGANGLIONIC NEURONES IS ASSOCIATED WITH NEURONAL NITRIC OXIDE SYNTHASE-DEPENDENT PROLOGATION OF VENTRICULAR EFFECTIVE REFRACTORY PERIOD R Ang
London UK
11:15 A DYNAMIC-CLAMP STUDY OF L-TYPE Ca2+ CURRENT IN RABBIT AND HUMAN ATRIAL MOCYTES: THE CONTRIBUTION OF WINDOW ICaL TO EARLY AFTERDEPOLARISATIONS A Workman
Glasgow UK
11:30 WHOLE EXOME SEQUENCING IN SUDDEN INFANT DEATH SYNDROME L Wong
London UK
11:45 MEDIUM TERM SURVIVAL AND FAMILY SCREENING OUTCOMES IN AN IDIOPATHIC VENTRICULAR FIBRILLATION COHORT - A MULTICENTRE EXPERIENCE S Hanarbakhsh
London UK
12:00 CLINICAL CHARACTERISTICS OF SCD SURVIVORS WITH BRUGADA SYNDROME:- ARE SPONSANEOUS TYPE I ECG AND PREVIOUS SYNCOPE REALLY ASSOCIATED WITH HIGH RISK? K Leong London UK
12:15 Close     


08:30-12:15 Pharmacy Workshop - Hall 8a 

Chair: S Antoniou & H Williams
  London UK; London UK
08:30 Addressing unmet needs in detecting AF across the globe  T Lobban
Stratford Upon Avon UK
08:40 Review of devices for early detection N Hamedi
London UK
09:00 Fighting AF by early detection - key learnings from Australia and the value of community pharmacists B Freedman
Sydney AU
09:20 Lessons learnt for a UK study, and ensuring a pathway from identification to treatment
S Antoniou
London UK
09:40 Discussion S Antoniou & H Williams
London UK;  London UK
10:00 Break    
Chair: F Alves da Costa & S Antoniou   Lisbon PT; London UK
10:45 Addressing unmet needs in managing AF across the globe  H Williams 
London UK
11:05 Medicines optimisation - improving anticoagulation nationally  S Gordon
Basingstoke UK
11:25 Optimising adherence in atrial fibrillation I Arnet
Basel CH
11:45 Universal guideline for optimal use of anticoagulation pharmacotherapy B van den Bemt 
Amsterdam NL
12:05 Discussion F Alves da Costa & S Antoniou Lisbon PT; London UK
12:15 Close     


08:30-17:15 Paediatric - Hall 8b

Chair:  J de Giovanni & O Uzun
  Birmingham UK; Cardiff UK
08:30 CPVT and provocative tests: reliability and value of adrenaline infusion versus exercise test O Uzun
Cardiff UK
08:50 Long QT and provocative tests: how to conduct and how to interpret V Bhole Birmingham UK
09:10 Brugada syndrome: timing, reliability and significance of positive provocative tests M Walsh
Bristol UK
09:30 My nightmare cases in the EP lab with SVT A Yue
Southampton UK
10:00 Break    
Chair:  J Gnanapragasam & G Stuart
  Southampton UK; Bristol UK
10:45 ARVC and diagnostic challenges: Clues to diagnosis in 12 lead ECG, SAECG, echocardiogram, MRI and Isoprenaline challenge S Sadagopan Leicester UK
11:15 Sport recommendations in children with arrhythmic disorders or sudden arrhythmic death syndromes E Rosenthal London UK
  Oral abstract presentations    
11:45 A NOVEL METHOD FOR FLUOROLESS SEPTAL PUNCTURE H Chubb London UK
11:51 ACCIDENTAL FOXGLOVE INGESTION IN A TODDLER R Fortner Cardiff UK
11:57 ATRIOVENTRICULAR CONDUCTION DELAY MAY BE MORE THAN SIMPLY INCREASED VAGAL TONE IN YOUNG ATHLETS M Scheller Cardiff UK
12:03 TARGETED GENETIC TESTING IN ASSISTING THE DIAGNOSIS OF LONG QT SYNDROME A Wong Cardiff UK
12:09 Questions    
12:15 Break    
Chair: K McLeod & J Till   Glasgow UK; London UK
13:30 The cardiac side effects of Stimulants, antipsychotics and antidepressants in children D Hares
Leeds UK
14:00 Antiarrhythmic medications: monitoring their efficacy, side effects and toxicity  J Till London UK
14:30 Clinical investigations for cardiac arrhythmias J de Giovanni Birmingham UK
15:00 Break    
Chair: E Rosenthal & M Walsh
  London UK; Bristol UK
15:45 Junctional ectopic tachycardia diagnosis and management K McLeod 
Glasgow UK
16:15 Arrhythmias in repaired congenital heart disease: frequency and therapeutic options G Stuart
Bristol UK
16:45 My nightmare cases in the EP lab with VT or defibrillator A Yue
Southampton UK
17:15 Close    

Registration fee - £35.00 (to attend study day only)*

If your payment hasn't been received before or on Friday 30 September 2016 your registration will become null and void and you will need to re-register.

*Does not include admission to exhibition for lunch and refreshments.

To register please email: info@heartrhythmcongress.org.uk

 

08:30-10:00 Optimal Management of AF and VT using the latest tools and techniques - Supported by St Jude Medical
Hall 9 

08:30 How EnSite Precision enhances my workflow K Rajappan Oxford UK
09:00 Management of VT cases with EnSite precision
S James Middlesbrough UK
09:30 New mapping tools and innovations for complex cases  M Lowe London UK
10:00 Close    


 

08:45-12:15 Cases & Traces (1) - Hall 10*

Chair:  S Allen, J Paisey
  Manchester UK; Southampton UK
 
08:48 Case 1 - ICD programming during VT ablation: The perils of not keeping it simple
  D Thomas Middlesbrough UK
09:00 Case 2 - Shocks after death: A failure of S-ICD sensing
   B Wiles
Southampton UK
09:12 Case 3 - AV node ablation: not always benign - an electropharmacology case study
  G Chu
Leicester UK
09:24 Case 4 - Narrow and  broad complex tachycardia - what is the mechanism?
  A Nisbet
Bristol UK
09:36 Case 5 - An unusual left sided pathway
  A Nisbet
Bristol UK
09:48 Case 6 - Difficult pathway ablation
  L Graham
Leeds UK
10:00 Break      
Chair:  J Paisey & A Rao
  Southampton UK; Liverpool UK
 
10:45 Case 7 - Just a secondary prevention in ICD...
  R Till
Bournemouth UK
10:57 Case 8 - High DFT and no simple solution
  B Wiles
Southampton UK
11:09 Case 9 - A Pregnant Pause
  S Murray
Newcastle Upon Tne UK
11:21 Case 10 - Image Guided wireless endocardial LV electrode implantation for CRT
  J Behar
London UK
11:33 The electrocardiography of myocardial repolarisation    D Rowlands
Cheadle UK
12:15 Close      

 *If you have a case you think would be of interest please submit a synopsis by email to john.paisey@nhs.net for consideration.

08:30-12:15 Improving AF Outcomes in the Lab - Supported by AF Association- Hall 11 

Chair:  R Schilling
  London UK
08:30 Contact Force for AF Ablation – Review & Comparison of Available Modalities M O'Neill
London UK
09:00 Long standing Persistent AF: what sub-categories predict better outcomes? M Earley
London UK
09:30 Use of Rhythmia for AF and AT mapping: what does it add over other mapping technologies? B Lim
London UK
10:00 Break    
10:45 The Role of Dual Left Atrial Appendage Isolation and Ligation: does it improve clinical results  S Panikker
London UK
11:15 How to tailor ablation prescription for individual patients: The role of substrate identification and targeting T Betts 
Oxford UK
11:45 Left Atrial Appendage Occlusion in the UK: what has 2 years of Commissioning through Evaluation taught us? D Gupta Liverpool UK
12:15 Close    


10:45-12:15 Master Class Devices, Part 1 - Practical Management Issues - Hall 9

Chair: S Harris & J Sibley
  Basildon UK; Basildon UK
 
10:45 Device detected AF and atrial high rate episodes
P Kirchhof Birmingham UK  
11:15 Device deactivation: when to discuss with the patient, when to do it A Patwala 
Stoke on Trent UK
 
11:45 Device detected VT: How much VT is significant and is VT ablation the answer? M Mason
Uxbridge UK
 
12:15 Close    

 

10:45-12:15 Research Session - Interactive Area 

Chair: P Lambiase   London UK
10:45  The New Research Application process-what's changed & how do I navigate it? N Srinivasan
London UK
11.10 Developing National Research Networks and Pragmatic Clinical Trials
R Providencia
London UK
11.35 The UK Multicentre Trials Group -How it has enabled my national study. A Ng
Leicester UK
11.55 The power of patient surveys in assisting applications and undertaking research T Lobban Stratford Upon Avon UK
12:15 Close    


 

13:30-17:15 Young Investigators Competition - Hall 7 

Chair:  A Ng
  Leicester UK
Judges: P Lambiase; F Leyva & K Rajappan
  London UK; Birmingham UK; Oxford UK
13:30 GENETIC ANALYSIS IN THE EVALUATION OF UNEXPLAINED CARDIAC ARREST: FROM THE CARDIAC ARREST SURVIVORS WITH PRESERVED EJECTION FRACTION REGISTRY (CASPER) G Mellor
Cambridge UK
14:00 IN-VIVO WHOLE HEART CONTACT MAPPING DATA AND A SIMPLE MATHEMATICAL FRAMEWORK TO UNDERSTAND THE INTERACTIONS BETWEEN ACTIVATION AND REPOLARIZATION RESITUTION DYNAMICS IN THE INTACT HUMAN HEART  M Orini
London UK
14:30 THE K(ATP) CHANNEL OPENER DIAZOXIDE REDUCES AUTOMATICITY IN AN IN VITRO ATRIAL CELL MODEL - POTENTIAL FOR K(ATP) CHANNELS AS A DRUG TARGET FOR ATRIAL ARRHYTHMIAS
M Specterman
London UK
15:00 Break

15:45 LONG-TERM OUTCOMES AFTER CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN PATIENTS WITH STRUCTURAL HEART DISEASE: A MULTICENTRE UK STUDY V Sawhney
London UK
16:15 THE BURDEN OF ARRHYTHMIAS IN LIFE-LONG ENDURANCE ATHLETES A Merghani London UK
16:45 CARDIAC MAGNETIC RESONANCE IMAGING RISK STRATIFICATION USING MARKERS OF REGIONAL AND DIFFUSE FIBROSIS FOR MEDIUM TO IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY: THE VALUE OF T1 MAPPING IN NON-ISCHEMIC PATIENTS S Claridge 
London UK
17:15  Close


13:30-17:15 Nurses - Hall 8a 

Chair:  H Bugden & S Holding
  Cambridge UK; Leeds UK
13:30 Management of atrial arrhythmias post AF ablation A Griffiths Oxford UK
14:00 Primary and Secondary Care working together to manage AF more effectively: One Centre's Experience J Mudd
Middlesbrough UK
14:30 Identifying AF: AliveCor in practice S Holding Leeds UK
15:00 Break
   
15:45 Cost effectiveness of ILR used for detection of cryptogenic stroke K Witte 
Leeds UK
16:30 ICD Deactivation: one centre's experience G Richards
 
Bournemouth UK
16:50 Device infection: surgical site surveillance  M Rouchon London UK
17:15 Close    

 

13:30-15:00 Master Class Devices, Part 2 - Hall 9 

EGM troubleshooting, Part 1 - Interactive Session
 
Chair: S Allen & I Wright
  Manchester UK; London UK
Panel: P Doherty & P Moore
  Stratford Upon Avon UK; Watford UK
Interactive session Test your EGM knowledge via the voting App    
13:30 EGM interpretation part 1 - case studies
   
14:15 EGM interpretation part 2 - case studies
   
15:00 Close    

 

13:30-15:00 Physiological rate adaption - does it work? - Supported by BIOTRONIK - Hall 10 

Chair:  R Kaba
  London UK
13:30 What is Closed Loop Stimulation and what is unique about it? J Steffel
Zurich CH
14:00 Case study: How CLS changed a teenagers life for the better
M Walsh
Bristol UK
14:30 Optimal rate responsive pacing in heart failure patients: what is the evidence? C de Cock
Amsterdam NL
15:00 Close    

 


13:30-17:15 Improving Arrhythmia Management (1)
Supported by Arrhythmia Alliance - Hall 11 

Chair:  A Brandes
  Odense DK
13:30 Obesity & Arrhythmias  R Pathak
Adelaide AU
14:00 Impact of sleep-disordered breathing on the genesis of arrhythmias D Linz
Homburg DE
14:30 My patient with inherited arrhythmia syndrome wants to perform exercise - What is the right advice? M Borggrefe Mannheim DE
15:00 Break
   
Chair:  N Sulke
  Eastbourne UK
15:45 Neuromodulation for Cardiac Arrhythmias D Linz Homburg DE
16:15 Primary prophylactic ICD in patients with non-ischaemic dilated cardiomyopathy - State-of-the-Art A Brandes Odense DK
16:45 The arrhythmia risk of psychiatric drugs N Gall
London UK
17:15 Close    


13:30-15:00 GUCH Heart Rhythm Management 1 - Interactive Area, Hall 3 

Chair: V Ezzat
  London UK
13:30 Guch anatomy, imaging and surgery – all you need to know M Lowe
London UK
13:55 Guch arrhythmias l – why, what and which drugs are best? G Stuart Bristol UK
14:15 Guch arrhythmias ll – which patients need ablation and how do I do it? S Ernst London UK
14:40 Guch arrhythmias lll – which patients need a device and how do I do it? E Rosenthal London UK
15:00 Close    

 

15:00-15:45 Moderated Posters (1) - Hall 3 Poster Area

Chair: R Hunter, London UK & C Plummer, Newcastle Upon Tyne UK

 

15:45-17:15 Master Class Devices, Part 3 - Getting the Most Out of CRT - Hall 9

Chair:  K Lascelles & A Rao
  London UK: Liverpool UK
15:45 Utilising CRT algorithms-can they improve CRT response? (i.e. MPP, Adaptive CRT etc.) A Patwala
Stoke on Trent UK
16:15 Impact of QRS duration and morphology on CRT effectiveness
T Betts
Oxford UK
16:45 My CRT patient now has AF: what do I do? >Pacing strategies vs. AF ablation S Harris Basildon UK
17:15 Close    


15:45-17:15 Master Class EP, Part 1 - Hall 10 

Chair:  J Paisey & I Wright   Southampton UK; London UK
15:45 Non-Invasive assessment of Arrhythmias  B Lim
London UK
16:15 Atrial Fibrillation Ablation Empiric approach vs Patient specific approach J Gill & M Wright
London UK; London UK
16:45 Electrograms 101 S Tan
Basildon UK
17:15 Close    

 

15:45-17:15 GUCH Heart Rhythm Management 2 - Interactive Area, Hall 3

Chair: J Mangat
  London UK
  Training in GUCH arrhythmia management    
15:45 What I have learnt from the GUCH clinic V Ezzat
London UK
16:00 What I have learnt from the EP Lab W Ullah Southampton UK
16:15 What I have learnt from my Fellowship M Ilina
Glasgow UK
Chair: M Lowe
  London UK
16:30 Debate:    
  GUCH ablations and device implantation should only be undertaken by a GUCH arrhythmia specialist    
  For  M O'Neill
London UK
  Against  J McCready
Brighton UK
17:15 Close    

 

Endorsed By